Loading clinical trials...
Loading clinical trials...
A Phase 3, Randomized, Observer-blind, Controlled, Multi-Center Study to Compare the Safety of One Dose of Novartis Meningococcal ACWY Conjugate Vaccine With That of a Licensed Meningococcal ACWY Polysaccharide Vaccine (Menomune®) Administered to Healthy Children 2 to 10 Years of Age
Conditions
Interventions
Meningococcal ACWY-CRM conjugate vaccine
Meningococcal ACWY-PS polysaccharide vaccine
Locations
3
Argentina
FUNCEI, French 3085
Buenos Aires, Argentina
Centro di Desarrollo de Proyectos Avanzados (CEDEPAP) Roma 1464
Córdoba, Argentina
Hospital de Pediatria "Sor Maria Ludovica", Calle 14 N1631,(1900)
La Plata, Argentina
Start Date
May 1, 2006
Primary Completion Date
March 1, 2007
Completion Date
March 1, 2007
Last Updated
October 9, 2018
NCT01725217
NCT03694405
NCT04358731
NCT01896596
NCT02811120
NCT03089086
Lead Sponsor
Novartis Vaccines
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions